OTCBB:RGRX

Regenerx Biopharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy RGRX

*Your capital is at risk

$0.0006

+0 (+0%)

At Close: Jun 03, 2026

Regenerx Biopharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 38.64M and sold 716K RGRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	38.64M shares
● Sell	716K shares
96% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 30, 2021 Buy	Series B Common Stock Warrant (right to buy) P-Purchase	Goldstein Allan L Director	Director	93 750 Value: $26.3K
Jun 30, 2021 Buy	Series A Common Stock Warrant (right to buy) P-Purchase	Goldstein Allan L Director	Director	93 750 Value: $22.5K
Jun 30, 2021 Buy	Common Stock P-Purchase	Goldstein Allan L Director	Director	125 000 Value: $25.0K
Jun 30, 2021 Buy	Series B Common Stock Warrant (right to buy) P-Purchase	Finkelstein J J President And CEO	CEO / President	56 250 Value: $15.8K
Jun 30, 2021 Buy	Series A Common Stock Warrant (right to buy) P-Purchase	Finkelstein J J President And CEO	CEO / President	56 250 Value: $13.5K
Jun 30, 2021 Buy	Common Stock P-Purchase	Finkelstein J J President And CEO	CEO / President	75 000 Value: $15.0K
Jun 30, 2021 Buy	Common Stock P-Purchase	Cavazza Paolo 10 Percent Owner	10% Owner	1 500 000 Value: $300.0K
Jun 30, 2021 Buy	Common Stock Warrant (right to buy) J-Other	Cavazza Paolo 10 Percent Owner	10% Owner	1 125 000 Value: $270.0K
Jun 30, 2021 Buy	Common Stock Warrant (right to buy) J-Other	Cavazza Paolo 10 Percent Owner	10% Owner	1 125 000 Value: $315.0K
Jun 30, 2021 Buy	Common Stock Warrant (right to buy) J-Other	Cavazza Paolo 10 Percent Owner	10% Owner	1 125 000 Value: $315.0K
Jun 30, 2021 Buy	Common Stock Warrant (right to buy) J-Other	Cavazza Paolo 10 Percent Owner	10% Owner	1 125 000 Value: $270.0K
Jun 30, 2021 Buy	Common Stock P-Purchase	Cavazza Paolo 10 Percent Owner	10% Owner	1 500 000 Value: $300.0K
Dec 31, 2020 Buy	Common Stock J-Other	Goldstein Allan L	Director	0 Value: $0
Dec 31, 2020 Buy	Common Stock J-Other	Goldstein Allan L	Director	0 Value: $0
Oct 15, 2020 Buy	Common Stock Warrant (right to buy) P-Purchase	Goldstein Allan L Director	Director	10 440 Value: $5K
Oct 15, 2020 Buy	Convertible Promissory Note (right to buy) P-Purchase	Goldstein Allan L Director	Director	0 Value: $0
Oct 15, 2020 Buy	Common Stock Warrant (right to buy) P-Purchase	Finkelstein J J President And CEO	CEO / President	20 880 Value: $9K
Oct 15, 2020 Buy	Convertible Promissory Note (right to buy) P-Purchase	Finkelstein J J President And CEO	CEO / President	0 Value: $0
Oct 15, 2020 Buy	Common Stock Warrant (right to buy) P-Purchase	Bove Mauro Director	Director	20 880 Value: $9K
Oct 15, 2020 Buy	Convertible Promissory Note (right to buy) P-Purchase	Bove Mauro Director	Director	0 Value: $0
Oct 15, 2020 Buy	Convertible Promissory Note (right to buy) P-Purchase	Bove Mauro Director	Director	0 Value: $0
Oct 15, 2020 Buy	Common Stock Warrant (right to buy) P-Purchase	Bove Mauro Director	Director	20 880 Value: $9K
Oct 15, 2020 Buy	Convertible Promissory Note (right to buy) P-Purchase	Finkelstein J J President And CEO	CEO / President	0 Value: $0
Oct 15, 2020 Buy	Common Stock Warrant (right to buy) P-Purchase	Finkelstein J J President And CEO	CEO / President	20 880 Value: $9K
Oct 15, 2020 Buy	Convertible Promissory Note (right to buy) P-Purchase	Goldstein Allan L Director	Director	0 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT REGENERX BIOPHARMACEUTICALS INC

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous sys...

Read Full Profile Here